Pharmaceutical companies have invested heavily in omnichannel strategies to deliver personalized, data-driven customer engagement across digital and in-person touchpoints. While early wins like AI-powered content orchestration and improved engagement rates are encouraging, many organizations are still navigating challenges such as organizational silos, regulatory constraints, and technology adoption hurdles.
Dive into the latest insights from Axtria Ignite 2025, where a panel of senior life sciences leaders from Regeneron, Merck, Gilead, Novo Nordisk, and Bristol Myers Squibb candidly shared both successes and challenges, along with practical solutions for making omnichannel a sustainable, high-impact approach.
As budgets tighten and expectations rise, the ability to “do more with less” will separate leaders from followers. Discover how next-gen AI tools such as agentic AI and generative AI are reshaping omnichannel approaches, and learn from real-world experiences in overcoming organizational, technological, and regulatory barriers.
Download the full report to explore actionable strategies, expert advice, and next steps to transform your omnichannel vision into measurable, scalable results.